◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksO › ORGO

Organogenesis Holdings Inc. (ORGO) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-11

Organogenesis Holdings Inc. (ORGO) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Canton, United States with about 854 employees. Its market capitalization is roughly $197 million. In the fiscal year ended 2025-12-31, ORGO reported $563M in revenue and $37M in net income.

Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.

Interactive charts & full statements → Open the ORGO valuation workbench →

ORGO Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$563M$482M$433M$451M
Gross Profit$426M$366M$327M$346M
Operating Income (EBIT)$56M$22M$12M$22M
Net Income$37M$1M$5M$16M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ORGO Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$43M$36M$225M$150M$101M
Gross Profit$19M$10M$175M$114M$73M
Operating Income (EBIT)($52M)($69M)$65M$22M($11M)
Net Income($96M)($53M)$44M$22M($9M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ORGO Free Cash Flow History

ORGO Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$599M$498M$460M$449M
Total Liabilities$165M$113M$181M$184M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ORGO viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

← OREGEAll “O” companiesORI →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.